Observational Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Nov 27, 2024; 16(11): 3520-3530
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3520
Table 1 Status of 186 cases of pseudomyxoma of abdominal cavity treated by cell reduction combined with intraperitoneal hyperthermic chemotherapy, n (%)
Variable
Number of cases
Primary site
    Appendix170 (91.4)
    Ovary15 (8.1)
    Location1 (0.5)
Pathological type
    Low-level99 (53.2)
    High level57 (30.6)
    Not quite clear30 (16.1)
Lymph node metastasis
    Correct19 (10.2)
    Deny151 (81.2)
    Suspicious transfer16 (8.6)
Meningeal tumor index score
    ≤ 107 (3.8)
    11-2034 (18.3)
    21-3056 (30.1)
    31-3955 (29.6)
Not quite clear34 (18.3)
    CCR rating
    CCR-015 (8.1)
    CCR-140 (21.5)
    CCR-2/3113 (60.8)
Not quite clear18 (9.7)
Whether to combine organ resection
    Correct123 (66.1)
    Deny63 (33.9)
HIPEC count
    130 (16.1)
    248 (25.8)
    379 (42.5)
    425 (13.4)
    54 (2.2)
HIPEC drugs
    Raltitrexed47 (25.3)
    Letotrexate + Oxaliplatin + Mitomycin42 (22.6)
    Platinum32 (17.2)
    Letotrexate + Oxaliplatin25 (13.4)
    Letotrexate + Mitomycin20 (10.8)
    Mitomycin8 (4.3)
    Oxaliplatin + Mitomycin8 (4.3)
    Other4 (2.2)